F5 and autoimmune polyendocrinopathy: 12 (15%) patients were carriers of factor V Leiden, 5 (6.25%) patients had 2021A prothrombin mutation, 5 (6.25%) had deficiency of antithrombin, protein C or S, while antiphospholipid syndrome (APS) was observed in 5 (6.25%) patients.